Philogen s.p.a
Webb20 mars 2024 · Philogen Spa a annoncé lundi qu'elle avait acheté 2 185 de ses propres actions ordinaires entre le 13 et le 17 mars. Les actions ont été acquises à un prix moyen de 15,7088 euros par action ... Webb2 juli 2024 · Prof. Dr. Dario Neri, Co-Founder, Chief Executive Officer and Chief Scientific Officer of Philogen S.p.A., said: “We are extremely pleased to see that our technology has been delivering exciting ...
Philogen s.p.a
Did you know?
WebbPhilogen S.p.A., a privately held clinical‐stage biopharmaceutical company, today announced that it has entered into a strategic worldwide license agreement with Pfizer for Dekavil, a novel investigational therapy for autoimmune diseases. Philogen will receive an upfront payment and Webb11 apr. 2024 · Philogen Spa heeft dinsdag bekendgemaakt dat het tussen 3 en 6 april 3.481 eigen gewone aandelen heeft ingekocht. De aandelen werden verworven tegen een gemiddelde prijs van EUR16,1055 per aandeel,... 11 april 2024
Webb11 apr. 2024 · Philogen purchased 3,481 shares of its own common stock. (Alliance News) - Philogen Spa reported Tuesday that it purchased 3,481 of its own ordinary shares … WebbPhilogen S.p.A. P.IVA e numero iscrizione CCIAA 00893990523 R.E.A. n. 98772 Cap. Soc. Euro 5.731.226,64 Int. Vers. AVVISO DI PUBBLICAZIONE DELLA DOCUMENTAZIONE RELATIVA ALL’ASSEMBLEA DEGLI AZIONISTI CONVOCATA PER IL 28 APRILE 2024
WebbPhilogen S.p.A. © Piazza La Lizza, 7 53100 Siena (SI) – ITALY Nr. REA: SI-98772 P.IVA e CF 00893990523 Cap. Soc. € 5.731.226,64 i.v. PEC: [email protected] WebbPhilogen´s encoded libraries of antibodies and small organic molecules are being used both for in-house discovery activities and for partnered programs. Our fully-owned …
Webb3 mars 2024 · All news about PHILOGEN S.P.A. 03/20: Philogen purchased more than 2,000 shares of its own common stock: AN. 03/17: Philogen S P A : to attend AACR Annual Meeting in Orlando on April 14-18, 2024: PU. 03/13: Philogen purchases its own shares for more than EUR27,000: AN. 03/06:
WebbPhilogen S.p.A., a privately held clinical‐stage biopharmaceutical company, today announced that it has entered into a strategic worldwide license agreement with Pfizer … 医療現場における5s活動医療生協かながわ生活協同組合Webb21 mars 2024 · Philogen koopt eigen aandelen in voor ruim 27.000 euro. AN. 06/03. Philogen heeft meer dan 4.000 eigen gewone aandelen ingekocht. AN. 27/02. Philogen … 医療生協さいたま セクハラWebbPhilogen S.p.A. 16,401 followers on LinkedIn. Innovating Targeting Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative ... 医療 生かしてみせるWebb11 apr. 2024 · Philogen : tra 16 e 19/8 acquistate 716 azioni. 2024. Philogen : allo 0,3862% del capitale dopo ultimi buyback. 2024. Philogen S.p.A. Announces Enrolment of 214 Patients in the Nidlegy Phase III European C.. b1 ポスター 保管 方法Webb31 dec. 2024 · Philogen S.p.A. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was EUR 23.71 million compared … b1 ポスター 印刷WebbPhilogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other … About us - Philogen is a Swiss-Italian biotechnology company Our Science - Philogen is a Swiss-Italian biotechnology company + Radiation – Non-Small Cell Lung Cancer – – – – Dodekin. Preclinical Philogen kindly invites you to attend a virtual briefing for analysts on 29 March … Work with us - Philogen is a Swiss-Italian biotechnology company Philogen S.p.A. publishes its regulatory disclosures through the SDIR-NIS circuit … The Board of Directors has appointed a Control, Risk and Sustainability … Small Molecule Therapeutics. Low molecular weight compounds can be … 医療 生かし方